These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 18287131)

  • 21. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
    García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
    Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.
    Mao X; Orchard G; Lillington DM; Russell-Jones R; Young BD; Whittaker S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):176-85. PubMed ID: 12696066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas.
    Rinaldi A; Kwee I; Poretti G; Mensah A; Pruneri G; Capello D; Rossi D; Zucca E; Ponzoni M; Catapano C; Tibiletti MG; Paulli M; Gaidano G; Bertoni F
    Br J Haematol; 2006 Jul; 134(1):27-36. PubMed ID: 16803564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular heterogeneity of B-lineage diffuse large cell lymphoma.
    Volpe G; Vitolo U; Carbone A; Pastore C; Bertini M; Botto B; Audisio E; Freilone R; Novero D; Cappia S; De Giuli P; Mazza U; Resegotti L; Palestro G; Saglio G; Gaidano G
    Genes Chromosomes Cancer; 1996 May; 16(1):21-30. PubMed ID: 9162193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
    Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
    Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
    Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
    Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of the t(14;18)(q32;q21) in patients with diffuse large B-cell lymphoma.
    Abdel-Ghaffar H; El-Aziz SA; Shahin D; Degheidy H; Selim T; Elsobky E; Attwan N; Al-Tonbary YA
    Cancer Invest; 2010 May; 28(4):376-80. PubMed ID: 19905895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
    J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).
    Beà S; López-Guillermo A; Ribas M; Puig X; Pinyol M; Carrió A; Zamora L; Soler F; Bosch F; Stilgenbauer S; Colomer D; Miró R; Montserrat E; Campo E
    Am J Pathol; 2002 Sep; 161(3):957-68. PubMed ID: 12213724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone.
    Heyning FH; Jansen PM; Hogendoorn PC; Szuhai K
    J Clin Pathol; 2010 Dec; 63(12):1095-100. PubMed ID: 20962053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
    Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
    Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
    Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C
    J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas.
    Giménez S; Costa C; Espinet B; Solé F; Pujol RM; Puigdecanet E; García-Moreno P; Sánchez J; Gallardo F; Estrach T; García-Muret P; Romagosa V; Serrano S; Servitje O
    Exp Dermatol; 2005 Dec; 14(12):883-90. PubMed ID: 16274455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.
    van Galen JC; Muris JJ; Giroth CP; Vos W; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Histopathology; 2008 Apr; 52(5):578-84. PubMed ID: 18312353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas.
    Guney S; Bertrand P; Jardin F; Ruminy P; Kerckaert JP; Tilly H; Bastard C
    Genes Chromosomes Cancer; 2011 Sep; 50(9):715-25. PubMed ID: 21638516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma.
    Stokke T; DeAngelis P; Smedshammer L; Galteland E; Steen HB; Smeland EB; Delabie J; Holte H
    Br J Cancer; 2001 Dec; 85(12):1900-13. PubMed ID: 11747333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas.
    Salaverria I; Martin-Guerrero I; Burkhardt B; Kreuz M; Zenz T; Oschlies I; Arnold N; Baudis M; Bens S; García-Orad A; Lisfeld J; Schwaenen C; Szczepanowski M; Wessendorf S; Pfreundschuh M; Trümper L; Klapper W; Siebert R
    Genes Chromosomes Cancer; 2013 Feb; 52(2):150-5. PubMed ID: 23073988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.